RIVANOVA
Our Portfolio
Acute, chronic and speciality therapies — each backed by validated processes, stability data and complete regulatory documentation.
Product categories
Every category below is manufactured in a dedicated, qualified block. Full product lists with compositions, pack sizes and pricing are shared on request against a valid drug licence.
Showing all 7 items
Film-coated, enteric-coated, dispersible and sustained-release tablets produced on high-speed rotary presses inside dedicated, humidity-controlled oral-solid blocks.
Hard gelatin and vegetarian HPMC capsules filled under laminar airflow, with pellet-in-capsule and multi-unit particulate options for modified release.
Dry-powder and liquid vials filled in Grade A/B aseptic suites with online particle monitoring, terminal sterilisation and 100% visual inspection.
Sugar-free syrups, dry syrups and palatable suspensions manufactured in closed-loop stainless steel vessels with in-line homogenisation and purified-water loops.
Emulsified creams, gels, lotions and ointments produced in vacuum homogenising vessels, filled into lami-tubes with controlled fill-weight verification.
Whey and casein based clinical nutrition powders blended in dehumidified suites, with amino-acid profiling and flavour-stability testing on every batch.
Evidence-led vitamin, mineral, omega and botanical formulations developed with bioavailability enhancers and validated shelf-life across climatic zones.
Therapeutic coverage
480+ SKUs mapped across twelve therapeutic areas, with depth concentrated where prescription volume and access gaps are greatest.
| Therapeutic area | Dosage forms available | Active SKUs | Primary channel |
|---|---|---|---|
| Anti-infectives | Tablets · Capsules · Dry syrup · Injectables | 96 | Retail & institutional |
| Cardio-diabetology | Tablets · Sustained-release tablets | 74 | Retail (chronic) |
| Gastroenterology | Capsules · Tablets · Suspensions | 58 | Retail |
| Analgesics & anti-inflammatory | Tablets · Gels · Injectables | 52 | Retail & institutional |
| Paediatrics | Syrups · Suspensions · Dispersible tablets · Drops | 46 | Retail |
| Dermatology | Creams · Ointments · Lotions · Tablets | 38 | Retail |
| Nutraceuticals & wellness | Softgels · Tablets · Sachets · Powders | 34 | Retail & e-commerce |
| Clinical nutrition | Powders · Sachets | 30 | Hospital & retail |
| Haematinics & women's health | Tablets · Capsules · Syrups | 26 | Retail |
| Critical care | Injectables (dry powder & liquid vials) | 14 | Institutional |
| Respiratory | Tablets · Syrups | 8 | Retail |
| Anaesthesia | Injectables | 4 | Institutional |
Packaging & presentation
A stable molecule in the wrong barrier is an unstable product. Packaging is selected from stability data under the actual climatic zone the product will be sold in — not from a catalogue default.
PVC, PVDC, Alu-Alu and cold-form laminates in 6, 10, 14, 15 and 30-unit configurations.
HDPE, amber PET and amber glass from 30 ml to 200 ml with measuring cup or dropper.
Type I and Type III glass, 2 ml to 30 ml, with flip-off seals and rubber stoppers.
Lami tubes 5 g to 100 g, and heat-sealed foil sachets for powders and granules.
Custom pack configurations, unit-dose presentations and export-specific artwork are developed against your market requirement.
Full compositions, pack sizes, MRP and trade terms are shared with holders of a valid drug licence. Tell us your territory and therapy focus and we will send the relevant sections.